Connect with us
European Gaming Congress 2024

Artificial Intelligence

Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction

Published

on

BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) — Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, allowing Merck KGaA, Darmstadt, Germany to assess Quris’ BioAI safety prediction platform, comparing it to traditional in vitro and in vivo approaches.

“The pharmaceutical industry is modernizing drug discovery, and innovations in AI hold significant promise,” noted Quris Scientific Advisory Board Member Dr. Robert S. Langer, co-founder of Moderna and lauded MIT professor. “As Quris expands its collaborations with pharmaceutical companies, this will hopefully lead to new ways to find novel drugs that safely meet patients’ needs in the years ahead.”

Quris’ BioAI safety prediction platform introduces a unique concept (18 granted and pending patents), which integrates miniaturized human tissues on a chip, nano-sensing, and machine learning, to predict which drug candidates will work safely in humans.

The collaborative project allows Merck KGaA, Darmstadt, Germany to assess Quris’ platform with the initial assessment focusing on identifying potential liver toxicity risks for drug candidates, with special emphasis on ones that preclinical experiments failed to identify. Subsequently, Merck KGaA, Darmstadt, Germany has the option to obtain up to a five-year exclusive license to a specific disease domain. Upon Merck KGaA, Darmstadt, Germany exercising the option, Quris may receive an undisclosed amount.

“The drug development process must be improved; drugs that are successful in mice, often still fail clinical trials in humans,” added Quris CEO Isaac Bentwich. “We are thrilled to be working with the Merck KGaA, Darmstadt, Germany team to assess Quris’ BioAI platform for clinical safety prediction.”

Advertisement
Stake.com

“In recent years, leaders around the globe have increasingly recognized that experiments in mice do not faithfully mimic what will work in people. With this and the goal to reduce and replace animal testing, there is now a great need for development of a new AI-based approach,” added Nobel Laureate Aaron Ciechanover, MD, DSc, Chairman of Quris’ Scientific Advisory Board. “Collaborations with pharmaceutical companies like Merck KGaA, Darmstadt, Germany, will help assess Quris’ BioAI platform for clinical prediction, which uniquely integrates AI along with miniaturized ‘patients-on-a-chip’. If successful, this could lead to a much-needed transformation in drug development speed, safety and cost.”

About Quris
Quris is a disruptive BioAI machine-learning platform that better predicts which drug candidates will safely work in humans, and allows the efficient discovery of new drugs and the repurposing and personalization of existing drugs. It generates proprietary classified data by testing thousands of known drugs on genetically diverse miniaturized ‘patients-on-a-chip’ that are uniquely available to Quris, and is based on Quris’ patented Chip-on-Chip technology. Dual-headquartered in Boston and Israel and backed by strategic biotech and big data investors, Quris is led by a proven team of AI and medical research powerhouses who are already preparing its lead discovery for clinical trials. For more information, visit www.quris.ai. Watch this video for more perspective on Quris’ technology breakthroughs.

For more information, please contact:
Erica Camilo
Tel. +1 610-639-5644

e-mail: [email protected]

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

APIX and RBI Join Forces to Drive Financial Innovation Through HaRBInger 2024 Hackathon

Published

on

apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon

SINGAPORE, June 21, 2024 /PRNewswire/ — APIX, the leading global collaborative innovation platform for financial institutions and fintechs across over 90 countries, today announced its partnership with the Reserve Bank of India (RBI) to host the prestigious HaRBInger 2024 hackathon. This landmark collaboration aims to bring together the brightest minds from around the world to develop cutting-edge solutions that enhance the security and inclusivity of the financial ecosystem.

Under the overarching themes of Combatting Fraud and Financial Inclusion for the Differently-abled, the hackathon challenges participants to tackle four critical problem statements focused on real-time fraud detection, ensuring transaction anonymity, identifying mule accounts, and empowering the visually impaired in financial transactions.
“At APIX Platform, we are thrilled and proud to once again partner with Reserve Bank of India (RBI) for HaRBInger,” shares Umang Moondra, CEO of APIX. “Reserve Bank of India (RBI) has led from the front in driving innovation in the financial services sector, and HaBRInger 2024’s focus on critical challenges related to fostering security, integrity, transparency, trust and inclusivity in digital transactions, is a testament to the leadership role that they play.”
As a trusted platform utilised by major banks and regulators worldwide, APIX is uniquely positioned to empower innovators and accelerate their journey toward bringing innovative ideas to life. Leveraging innovative technologies such as AI/ML, APIs, Data Analytics, and more, HaRBInger 2024 participants will have the opportunity to create solutions that drive meaningful change and leave a lasting impact on the financial services industry.
The hackathon welcomes individuals, teams, and enterprises from diverse backgrounds and geographies to participate, offering a platform to showcase their skills on a global stage. With exciting prizes up for grabs, including INR 40,00,000 (~USD 48,000) for the winner in each problem statement category and a special prize of INR 20,00,000 (~USD 24,000) for the best all-woman team, the opportunities are substantial.
Registration for HaRBInger 2024 started on June 7, 2024, and will unfold in four exciting phases on the APIX Platform: screening of entries, shortlisting for solution development, solution development with mentoring and support, and the selection of winners.
Don’t miss this opportunity to collaborate with like-minded innovators, gain exposure to industry leaders, and shape the future of finance on the APIX Platform.
For media inquiries or additional details about HaRBInger 2024, please contact [email protected].
For more information and to register now, visit HaRBInger 2024 at: https://hackolosseum.apixplatform.com/h1/harbinger2024
About APIX:
APIX is a collaborative innovation platform for fintechs and innovators across 90+ countries, empowering Financial Institutions to accelerate their innovation journey. 
Major banks, insurers, and regulators in the world use APIX to rapidly discover, test, and evaluate solutions by running comprehensive innovation programs, which include innovation challenges and hackathons. 
Ideas are everywhere. Bring the best to the table with APIX. Collaborate to innovate today at www.apixplatform.com.  
Logo – https://mma.prnewswire.com/media/2443613/4773081/01_LOGO_COLOR_WITH_BLACK__MAIN_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon-302178678.html

Continue Reading

Artificial Intelligence

Maxterial Raises nearly $8 Million in Series A Funding

Published

on

maxterial-raises-nearly-$8-million-in-series-a-funding

Reinforces Position as a Disruptive Force in Material Science Innovation

PLEASANTON, Calif., June 20, 2024 /PRNewswire/ — Maxterial, a technology company dedicated to pioneering advancements in material science including the commercialization of advanced coatings, has announced the successful closure of its Series A funding round, raising nearly $8 million. This milestone underscores Maxterial’s rising influence in disruptive material science technologies and its commitment to reshaping traditional industry norms with dynamic and environmentally responsible solutions.
Led by CEO Dr. Mehdi Kargar and Chief Technology Officer Dr. Amy Haghdoost, Maxterial has pioneered material science advancements for nearly a decade. The company’s lean approach to reaching the product-growth fit stage has garnered widespread acclaim, attracting a range of customers and influential investors, including Peter Thiel’s Breakout Labs, Pierre Omidyar’s UP2398, and corporate innovation leaders like Saint-Gobain and Anglo American.
The Series A funding round, led by Helios Climate Ventures, with participation from global corporation QEMETICA (formerly Ciech), solidifies Maxterial’s position as a leader in climate-conscious innovation. This capital enables Maxterial to accelerate its R&D efforts, including large-scale trials, expand its products, and scale operations in North America and Europe.
“We are thrilled to have secured nearly $11 million to date in equity financing, which reflects the confidence investors have in our vision, our unique go-to-market strategies, and the transformative potential of our technology,” said Dr. Mehdi Kargar, CEO of Maxterial. “This scalable platform fits many markets in urgent need of dynamic, sustainable solutions. Series A funding enables us to drive transformational growth across multiple industries.”
Maxterial replaces environmentally harmful and energy-inefficient processes using Hexavalent Hard Chrome (H-Chrome) with a superior solution that is safe, environmentally friendly, and cost effective at a time when material science startups have struggled to attract investment. The company breaks those cycles by delivering unique synergies that integrate the needs of investors, customers, supply chains, and industry experts with a product and service model that delivers exceptional performance, accelerates change and mitigates risk.
Maxterial has already gained significant initial traction. Ongoing trials in Europe and North America are attracting early adopters eager for cutting-edge solutions. By prioritizing sustainability, performance, and scalability, Maxterial can protect against wear, heat, and corrosion, reduce carbon footprint, and eliminate toxic materials like hexavalent chromium.
“We set out to create a company that delivers exceptional technology and exceptional returns,” notes Dr. Kargar. “As we accelerate our implementation, we want to share our insights and expertise with fellow entrepreneurs, industry leaders, and investors interested in driving positive change.”
For media inquiries, please contact:
Carmen FerrignoChief Marketing Officer, MaxterialPhone: 215.287.3658Email: [email protected]
About Maxterial:Maxterial is a Bay Area technology company dedicated to pioneering advancements in material science, including the commercialization of advanced coatings. Founded in 2015, Maxterial leverages an eco-systemic lean tech approach to develop innovative solutions that protect against wear, heat, and corrosion while reducing carbon footprint and eliminating toxic materials from industrial processes. Maxterial is committed to driving responsible transformation in the material science industry through thought leadership, innovation, and collaboration that inspires others to embrace responsible innovation.
To learn more, visit Maxterial.com
Logo – https://mma.prnewswire.com/media/2440672/Maxterial__Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/maxterial-raises-nearly-8-million-in-series-a-funding-302177099.html

Continue Reading

Artificial Intelligence

Altair Named a Leader in the June 2024 Gartner® Magic Quadrant™ for Data Science and Machine Learning Platforms

Published

on

altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant™-for-data-science-and-machine-learning-platforms

Altair recognized in the report’s Leaders’ Quadrant for Completeness of Vision and Ability to Execute
TROY, Mich., June 20, 2024 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, today announced that it has been positioned by Gartner as a Leader in the Magic Quadrant for Data Science and Machine Learning Platforms for its offering, Altair® RapidMiner®. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute.

According to the report, “Leaders in this market have a mature, refined, and targeted company and platform strategy that incorporates and leverages generative AI (GenAI) to drive their customers’ business value. They see opportunities for leveraging GenAI that other providers may not see or have made significant investments above and beyond standard offerings. They have the capability to innovate at a speed that outperforms other vendors. In addition, they can clearly articulate how they provide value to the multiple types of personas involved in the process of building data science and machine learning models.” 
“We believe being named as a Leader in this latest report validates what we have known for years: Altair has one of the market’s most unique, most comprehensive offerings for data analytics and machine learning,” said James R. Scapa, founder and chief executive officer, Altair. “For us, this placement is also a testament to our unmatched vision, which has defined us since our inception. We are pioneers that define what it means to be at the forefront of technological innovation and computational intelligence. I am incredibly proud of where Altair stands today, and I look forward to the strides we continue to make each day.”
Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables you to get the most from market analysis in alignment with your unique business and technology needs.
View a complimentary copy of the Magic Quadrant report to learn more about Altair’s strengths and cautions, among other provider offerings, at https://web.altair.com/gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-2024.
Gartner Disclaimer
Gartner, Magic Quadrant for Data Science and Machine Learning Platforms, Afraz Jaffri, Aura Popa, Peter Krensky, Jim Hare, Raghvender Bhati, Maryam Hassanlou, Tong Zhang, 17 June 2024.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Altair
Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world – all while creating a greener, more sustainable future. To learn more, please visit www.altair.com.
Media contacts
Altair Corporate                                           
Altair Investor Relations
Bridget Hagan                                             
Stephen Palmtag
+1.216.769.2658                                         
+1.669.328.9111
[email protected]                       
[email protected]
Altair Europe/The Middle East/Africa
Charlotte Hartmann
+49 7031 6208 0
[email protected]
 
Photo – https://mma.prnewswire.com/media/2444041/Altair_Newsroom_NR_Gartner_MQ_Social__2.jpg
Logo – https://mma.prnewswire.com/media/1421069/Altair_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-302178198.html

Continue Reading

Trending